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ABSTRACT
Complex carbohydrates from plant sources, such as the fruits of cranberry (Vaccinium
macrocarpon Aiton), promote human health in a variety of ways (1-4). However, complete
studies of carbohydrate function often hinge on a detailed understanding and thorough
elucidation of the chemical structure. Several methods have been used in the structure
elucidation of cranberry oligosaccharides, such as derivatization followed by analysis using gas
chromatography-mass spectrometry (GC-MS). In this manner, the identity and quantity of
glycosyl units within two cranberry oligosaccharides were investigated through hydrolysis of the
oligomers and subsequent synthesis of trimethylsilyl and alditol acetate derivatives. Further
analysis using partially methylated alditol acetate derivatives revealed the linkage position on
each glycosyl unit. A complete structure was assembled through the compilation of data from
the analysis of 1D and 2D NMR experiments yielding two novel oligosaccharides, the
heptasaccharide β-D-glucopyranosyl-(1→4)-[α-D-xylopyranosyl-(1→6)]-β-D-glucopyranosyl(1→4)-β-D-glucopyranosyl-(1→4)-[α-L-arabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-βD-glucopyranose (1)

and the octasaccharide β-D-glucopyranosyl-(1→4)-[α-L-arabinofuranosyl-

(1→2)-α-D-xylopyranosyl-(1→6)]-β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyl-(1→4)-[α-Larabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-β-D-glucopyranose (2).
Cranberry products are known to contain several biological activities, such as antioxidant
properties (5), antiproliferative properties against several cancer cell lines (6-8), and
antimicrobial and antiviral properties (9, 10). In addition, several clinical trials and in vitro
analyses have assessed the ability of cranberry products and extracts to aid in the treatment of
ii

urinary tract infections via prevention of adhesion of bacteria to uroepithelial cells (11-14).
Cranberry extracts enriched with oligosaccharides, including compounds 1 and 2, were assessed
for biological activity. Bioassays included an antimicrobial screen against 10 different
pathogenic organisms, a breast cancer cell viability assay, and an anti-adhesion assay involving
E. coli and human uroepithelial cells. While antimicrobial, anticancer, and anti-adhesion activity
was not confirmed for purified compounds 1 and 2, the parent fraction exhibits activity which
prevents the adhesion of P-fimbriated E. coli to uroepithelial cells. This activity suggests the
importance of oligosaccharide-enriched fractions in the anti-adhesion activity of cranberry
products.
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CHAPTER 1
STRUCTURE ELUCIDATION OF CRANBERRY OLIGOSACCHARIDES
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1.1 Introduction
Complex carbohydrates, such as protein-bound and free oligosaccharides, from natural
sources are involved in human health in a variety of ways (1, 15). For instance, oligosaccharides
are being investigated as anti-adhesion agents for use in the treatment or prevention of infectious
disease (2, 16). Glycol portions of a mucosal cell glycoconjugate are often involved in bacterial
adhesion to such cells. The mechanism to prevent adhesion of bacteria is through competitive
attachment of free oligosaccharides that mimic the structure of the glycol portion of the
glycoconjugate to which bacterial adhesins bind (16). Health benefits of oligosaccharides
include immune effects such as the immunostimulatory properties of mushroom β-glucans (17)
and inhibition of the human complement pathway by brown algal fucoidan oligosaccharides (3).
Recently, much attention has been given to the stimulation of a beneficial gastrointestinal (GI)
microbiota by oligosaccharides found in an assortment of natural sources such as grain products,
Norway spruce (Picea abies), and wine (4, 18-20). Oligosaccharides selectively fermented by
GI flora, resulting in either a compositional change in the microbiota or changes in their
metabolic activity and generating a beneficial effect on health, are known as prebiotics (4).
Understanding the structure of an oligosaccharide is a key element to understanding its
bioactivity. In the case of bacterial adhesins, specific bacterial species, even strains of the same
species, bind to specific carbohydrate moieties on glycoconjugates present on a particular cell
type. For example, the urinary pathogen Escherichia coli Type 1 has adhesins that bind to
Manα3Manα6Man present on epithelial cells in the lower urinary tract, rendering it susceptible
to the anti-adhesive properties of D-mannose. Conversely, P fimbriated E. coli adhesins bind to
Galα4Gal present on the surface of upper urinary tract epithelial cells and are inherently resistant
to D-mannose anti-adhesive effects. NMR and molecular modeling based structure-activity
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studies of the fucoidan oligosaccharides have highlighted that the decrease in flexibility of the
oligosaccharide backbone promotes binding to the C4 receptor protein in the classical
complement pathway (3). It is the presence of side chains in some fucoidan oligomers that
results in the decreased backbone flexibility. Further, the structural characteristics of prebiotic
oligosaccharides can stimulate growth of specific types of GI flora, with bifidobacteria and
lactobacilli most often effected (4). In vitro examinations indicate that glycosyl composition, for
example the ratio of xylose to arabinose residues in xylo-oligosaccharides (18), degree of
polymerization, and degree of branching effect the fermentation of oligosaccharides (4, 18, 19,
21). Overall, it is clear that a complete understanding of a compound’s bioactivity hinges on a
thorough examination of the molecular structure.
Many techniques have been reported regarding structure elucidation of oligosaccharides.
The complexity of compounds addressed range from di- and trisaccharides to molecules with
over 50 degrees of polymerization (4, 21, 22). Analytical techniques include hydrolysis and
analysis of glycosyl identity and quantity (22), permethylation (23, 24) and methanolysis
combined with gas-liquid chromatography (GLC) (22, 25), and trimethylsilyl derivatization
combined with gas chromatography-mass spectrometry (GC-MS) (26). Advanced NMR
techniques aid in the full structural assignment of carbohydrates and are also utilized in structureactivity studies (3, 22, 27). Owing to the enormous variety of structures that are possible in
complex carbohydrates, a combination of methods is necessary to assess the complete structure.
In the present work, two novel oligosaccharides isolated from cranberry fruit (Vaccinium
macrocarpon Aiton, Ericaceae) products have been investigated. A variety of techniques
employed in the structure elucidation (Figure 1.1) are utilized to provide absolute confidence in
the structural assignment of these complex molecules. The process begins with the
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determination of molecular weight, achieved via permethylation of the compounds and analysis
with high resolution mass spectrometry (HRMS); this information subsequently provides the
degree of polymerization (DP). The DP is applied to the results of the quantification and
identification of glycosyl units assessed with alditol acetate derivatization (Figure 1.2 A)
followed by GC-MS analysis. The alditol acetate derivatization involves the reduction of
hydrolyzed glycosyl residues from the aldehyde to the alditol form and subsequent O-acetylation
of the hydroxy groups. In this analysis, a molar ratio between the participating glycosyl units is
produced and, in combination with the DP, the actual number of glycosyl types is determined.
For example, if the ratio of monosaccharides is 2 Glc:1 Xyl then with a DP of 3, it is established
that two Glc units and one Xyl unit are present, rather than four Glc and two Xyl units. At this
point, several questions still remain about the structure of these complex carbohydrates, such as
what is the ring size and stereochemistry of each monomer and how are they linked together?
The partially methylated alditol acetate (PMAA, Figure 1.2 B) derivative analysis affords the
details of ring size and linkage position for each individual monomer and the phenyl
thiocarbamate derivative analysis (Figure 1.2 C) allows the assignment of D or L configuration
based on the absolute configuration of C-4 and C-5 for pentose and hexose saccharides,
respectively. These methods are further explained in the Results and Discussion section.
Finally, 1D and 2D NMR experiments are employed to establish the configuration at the
anomeric carbon as α or β as well as establish the connectivity of the monomers (HMBC doubleheaded arrow in Figure 1.1). With the pieces of information from each experiment pulled
together, each complexity of the oligosaccharide structure is addressed yielding a thorough
elucidation of the two novel oligosaccharides presented herein (Figure 1.3).
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Figure 1.1. Structure elucidation of a hypothetical trisaccharide employed for compounds 1 and 2.

Figure 1.2. Chemical derivatizations of compounds 1 and 2. Alditol acetate (A), partially
methylated alditol acetate (B), and phenyl thiocarbamate (C) derivatizations.

NaBD4
NH4OH

2 M TFA
121 °C

Ac2O
TFA, 50 °C

a)

a)

c)

b)

b)

d)

c)
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d)

Figure 1.3. Chemical structure of compounds 1 and 2.

7

1.2 Experimental Methods

Solvents and chemicals
Derivatization: Solvents were purchased from Fisher Chemicals and are ACS certified
unless otherwise stated. DMSO and MeOH were both dried with a 3 Å molecular sieve.
Chemical reagents include Tri-Sil reagent (Thermo Scientific), L-cysteine methyl ester (Aldrich),
and phenyl isothiocyanate (Aldrich).
Standards: All carbohydrate standards were purchased from Sigma unless otherwise
stated: cellotetraose (Dextra, Reading, UK), L-(+)-arabinose, D-(-)-arabinose, D-(+)-glucose, L(-)-xylose, D-(+)-xylose, D-(+)-fucose, L-(+)-rhamnose monohydrate, myo-inositol (Sigma).

Isolation
Two starting materials were used: Sundown Naturals® brand cranberry fruit powder in
475 mg capsules (SN) and Ocean Spray® spray-dried cranberry juice powder (CJ) provided by
Ocean Spray Cranberries, Inc. The SN (after removal from capsules) and CJ powders (40.0 g
and 1 kg, respectively) were dissolved separately in 150 mL of H2O using 30 min of sonication.
The dissolved samples were centrifuged for 5 min at 1800 rpm and the supernatant of each was
decanted into separate 1 L separatory funnels. The precipitate isolated upon centrifugation was
washed twice with 100 mL and then 50 mL of H2O and the wash was added to the supernatant of
each respective sample, for a total of 300 mL of aq. solution for each sample. The samples were
extracted with 150 mL of EtOAc four times and the resulting aqueous and EtOAc fractions were
dried by rotary evaporation. A secondary extraction was carried out on the aqueous extract of SN
using EtOH in order to precipitate proteins and pectins. EtOH (500 mL) was added to 250 mL
of the aq. SN extract followed by sonication for 20 min. The resultant aq. extracts were
8

centrifuged for 5 min at 3000 rpm to remove precipitate. The supernatants were dried using a
combination of rotary evaporation and lyophilization.
The aqueous SN and CJ extracts were fractionated using Sephadex LH-20 (320 g dry
resin, Amberlite). The resin was equilibrated with 70% aq. EtOH resulting in a column with
dimensions of 70 x 36 x 7 cm. The SN and CJ aq. extracts were dissolved in 70% aq. EtOH
(13.7 g and 25.3 g, respectively) and centrifuged to remove any precipitate, resulting in 60 mL of
the SN sample and 100 mL of the CJ sample which were then separately loaded onto the
Sephadex LH-20 columns. Elution proceeded with 70% aq. EtOH at ~1.7 mL/min for the SN
sample. Two fractions (SN-03 and SN-04) containing the oligosaccharides eluted between 320
and 620 minutes with a larger quantity of oligosaccharides eluting in fraction SN-03 (320-450
min). The SN-03 and SN-04 fractions were dried to yield a lavender-maroon powder (3.62 g and
2.44 g, respectively). Elution of the CJ extract proceeded with the same solvent and flow rate
affording two oligosaccharide-containing fractions (CJ-03 and CJ-04) eluting between 350 and
600 minutes. The fractions were dried, yielding 3.98 g of CJ-03 and 1.74 g of CJ-04, a pinklavender powder. The combined yields of the oligosaccharide fractions comprise 44.3 and
22.6% of the aq. SN and CJ extracts, respectively. When assessed by analytical scale HPLCUV-ELSD, the oligosaccharide-containing fractions afforded a unique chromatographic profile
as shown in Figure 1.4. The conditions employed for this analysis include: Waters 2695
Separations Module; Waters 996 Photodiode Array Detector; Polymer Laboratories PL-2100
ELS detector (ELSD); stationary phase, Atlantis dC18 column (4.6 x 150 mm, 5 µm); UV
Maxplot 210-400 nm; ELSD gas flow1.0 SLM, nebulizer temp. 45 °C, evaporator temp. 90 °C;
mobile phase gradient 0-5 min H2O, 5-35 min H2O to 30% aq. MeOH, 35-45 min 30 to 100%
MeOH.
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Figure 1.4. ELSD chromatogram of fraction SN-03 (Atlantis dC18 4.6x150 mm, 5 μm).

Further fractionation occurred using a Waters Delta Prep 4000 HPLC equipped with a
Waters 2487 Dual Wavelength Absorbance UV and Polymer Laboratories PL-1000 ELS
detectors in series. An Atlantis dC18 (19 x 250 mm, 10 μm) column was used as the stationary
phase and the mobile phase was a gradient from H2O to 40% aq. MeOH at 25 mL/min (Table
1.1). UV spectra were recorded at 210 and 254 nm and the ELSD conditions were as follows:
carrier gas, N2, gas flow 0.8 SLM, nebulizer temp., 50 °C, and evaporator temp. 100 °C. SN-03
(3.17 g) and CJ-03 (1.00 g) were dissolved in 9.2 and 4 mL of H2O, respectively, and filtered
through a 0.2 µm nylon membrane. Repeated injections were applied ranging from 400 to 600
µL each. Nine fractions were collected: fraction 4, collected from 25.5-26.8 min, contained
compound 1 as its major component and fraction 5, collected from 26.8-28.2 min, contained
compound 2 as its major component. SN-03 afforded 82.3 mg and 211.9 mg and CJ-03 afforded
55.7 mg and 96.6 mg of fractions 4 and 5, respectively. The quantity of fractions 4 and 5
constitutes 2.6 and 6.6% of SN-03, while fractions 4 and 5 constitute only 5 and 9% of CJ-03,
respectively. Fraction SN-03 constitutes a much larger portion of the aq. SN extract (44.3%) as
compared to CJ-03 which makes up 22.6% of the aq. CJ extract. This suggests that the yield of
fractions 4 and 5 may be higher in the SN fruit powder product as compared to the CJ juice
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powder product. However, almost 50% of the dry weight of the original SN product was
removed through the EtOH precipitation process. The final yield of compounds 1 and 2 are
~0.13 and 0.29% of SN and ~0.33 and 0.52% of CJ, respectively.

Table 1.1. General mobile phase method used for preparative scale fractionation of SN-03 and
CJ-03 (Atlantis dC18, 19 x 250 mm, 10 µm).
Time
% Solvent: H2O
% Solvent: MeOH
Curve*
100
0
6
0
100
0
6
10
70
30
6
50
100
0
6
53
100
0
6
65
*The curve profile of the gradient method indicates the change in solvent composition over the
time allotted. A curve profile of 6 is a gradual, linear change in the solvent composition from the
initial to the final solvent composition over the time segment of the gradient schedule. For
example, a linear change in solvent composition occurs from 10 min and 100% H2O to 50 min
and 30% aq. MeOH.

The final purification was completed using the same HPLC and detector conditions with
a YMC Polyamine II (20 x 250 mm, 5 μm) stationary phase and an isocratic mobile phase of
63% aq. MeCN. SN-03 fraction 4 (80.1 mg) was injected over several runs (200 µL injections)
yielding 31.0 mg of compound 1 which eluted at 25 min. SN-03 fraction 5 (169.4 mg) was
injected over several runs (~200 µL injections) eluting compound 2 at 28 min with a yield of
65.0 mg. CJ-03 fraction 5 (~60 mg) was injected over two runs (200 µL injections), eluting
compound 2 at 28 min with a yield of ~20 mg.
Intensive structural studies were carried out using oligosaccharides isolated from the SN
product. Accidental sample loss of CJ oligosaccharide samples prevented thorough study;
however, the presence of compound 2 could be confirmed through chromatographic and NMR
spectroscopic similarities and the presence of compound 1 is suspected.
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Permethylation
Compounds 1 and 2 (200-500 µg) were dissolved in 200 µL of dry DMSO in a screw-cap
tube and stirred for 1 hr after purging the headspace with N2. The base was freshly prepared
using 4 mL of dry DMSO added to 100 µL of 50% sodium hydroxide (w/w). The solution was
vortexed, centrifuged, and washed with dry DMSO repeatedly until salts and H2O were removed.
Dry DMSO (2 mL) was added to the washed hydroxide pellet. The resulting base (200 µL) was
added to each carbohydrate sample and stirred briefly, after which iodomethane (100 µL) was
added. The headspace of the screw-cap tube was purged with N2 and the solution was stirred at
room temperature for 40 min. This process was repeated followed by addition of H2O (2 mL) to
quench the reaction, yielding a cloudy solution. The remaining iodomethane was removed under
a low flow of N2. The permethylated carbohydrates were extracted into DCM (2 mL), washed
with H2O (2 x 2 mL), dried under N2, and further purified by solid phase extraction (SPE; C18E
Strata, Phenomenex). The SPE cartridge was conditioned with MeOH, then MeCN and finally
H2O and the dried carbohydrate extracts were loaded onto the cartridge with H2O and eluted with
MeCN. The samples were dried prior to ESI-QTOF-MS analysis.

Trimethylsilyl Derivatization
Compound 2 and two sets of standards were derivatized. Standard set 1 consisted of 50
µg each of arabinose, fucose, galacturonic acid, glucose, N-acetylglucosamine, and N-acetylmannosamine. Standard set 2 consisted of 50 µg each of rhamnose, xylose, glucuronic acid,
mannose, galactose, and N-acetylgalactosamine. myo-Inositol (20 µg) was added to 100 µg of
sample 2 and to each standard set in individual screw-cap tubes. The derivatization began with
methanolysis by heating the samples to 85 °C overnight after the addition of 500 µL of 1 M
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methanolic HCl (28). The samples were cooled and dried under N2 in a H2O bath at 40 °C during
which an additional 200 µL of dry MeOH was added. MeOH (200 µL), pyridine (100 µL), and
Ac2O (100 µL) were added to the dried samples and left for 30 min at room temperature, after
which the samples were dried as described above. Tri-Sil reagent (200 µL) was added and the
samples were heated at 80 °C and stirred for 20 min. The samples were concentrated to a minute
volume (~50 µL) and then 2 mL of hexanes was added. The samples were centrifuged for 30 sec
and the supernatant was removed and filtered through a glass wool-packed pipette and
concentrated to a volume of ca. 100 µL. The remaining sample was transferred to a 1.5 mL vial
with a septum-cap for GC-MS analysis.

Alditol Acetate Derivatization
The following samples were used to create alditol acetate derivatives: L-(+)-arabinose,
D-(+)-glucose, L-(-)-xylose, D-(+)-fucose, L-(+)-rhamnose, D-(+)-galactose,

myo-inositol, 1 and

2. The standards were prepared individually using the reported procedure (Whiton et al. 1985)
modified as described below, to assess retention time and fragmentation by GC-MS analysis. A
standard set of multiple monosaccharides (AAstd) was used to create a GC-MS calibration curve
for quantification purposes. Individual monosaccharide samples (100 µg each) were combined
with 20 µg of the internal standard, myo-inositol, in individual screw-cap tubes. The standard of
combined monosaccharides consisted of 50 µg each of L-(+)-arabinose, D-(+)-glucose, and L-(-)xylose, and 20 µg of myo-inositol. 1 and 2 (~100 µg each) were combined with 20 µg of myoinositol in a screw-cap tube and were hydrolyzed through incubation in 2 M TFA at 121 °C for
two hr, after which the samples were removed from heat and allowed to cool to room
temperature. Isopropanol (200 µL) was added and the samples were dried under a stream of N2
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while sitting in a H2O bath at 40 °C. The addition and subsequent drying of isopropanol was
repeated twice. The hydrolysis and drying were followed by reduction of the resultant
monomeric moieties from the oligosaccharides by incubating the samples in 200 µL of 10
mg/mL NaBD4 in 1 M NH4OH at room temperature overnight. The reduction reaction was
neutralized with five drops of glacial HOAc, followed by the addition of 5 drops of MeOH and
drying of the samples. Any remaining NaBD4 was removed by repeated addition and drying of
9:1 MeOH:glacial HOAc. The final step of O-acetylation of the reduced monomeric moieties
was carried out by the addition and brief mixing with 250 µL of Ac2O followed by addition and
incubation with 230 µL of TFA (99.9%) at 50 °C for 20 min. After the sample cooled, the
reaction concluded with the addition of isopropanol, which was subsequently dried and followed
by the addition of 0.2 M Na2CO3. The resulting alditol acetate derivatives were extracted from
the final solution using DCM (2 mL), washed with H2O (2 x 1 mL), and concentrated to ~100 µL
in preparation for GC-MS analysis.

Partially Methylated Alditol Acetate (PMAA) Derivatization
Preparation of standards: The PMAA standards were created from the following
monosaccharides: L-(+)-arabinose, D-(+)-glucose, and L-(-)-xylose, with the addition of myoinositol as an internal standard. Partial methylation of each monosaccharide was carried out
based on the methods described in Doares et al. (29). Briefly, methanolysis of each
monosaccharide was performed with the addition of 2 mL of 1 M methanolic HCl in a screw-cap
tube. Following incubation at 80 °C for two hours with stirring, 200 µL of t-butanol was added
and the samples were dried under flowing N2 while sitting in a H2O bath at 40 °C. Subsequently,
1 mL of MeOH was added and the samples were re-dried under N2 and finally in a vacuum oven.
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The resulting methyl glycosides were treated with freshly prepared 1M dimsyl anion at a volume
that provides the molar equivalence of the anion to 70% of the remaining free hydroxy groups in
each of the methyl glycoside standards. After 10 min of stirring, iodomethane was added (130
µL) and the mixture was stirred for an additional 10 min. The remaining iodomethane was
removed by placing the sample under a flow of nitrogen and eventually drying the samples. The
resulting partially methylated monosaccharide standards each underwent O-acetylation using 200
µL of 4-(dimethylamino)pyridine (120 mg/mL pyridine) and subsequent addition of 2 mL of
Ac2O with stirring for 10 min. O-acetylation of the samples allows for more efficient extraction
using DCM. The following treatment of the extracted and dried partially methylated standards
mimiced the method described for alditol acetate derivatization. This method employed
hydrolysis with 2 M TFA, reduction with NaBD4 in 2 N NH4OH, and O-acetylation with TFA
99.9% and Ac2O.
To create the PMAA derivatives of samples 1 and 2 (400 µg each), the oligosaccharides
were subjected to the permethylation procedure described above, which was immediately
followed by the alditol acetate procedure. Derivatives were reduced to a volume of ~100 µL in
DCM and injected into GC-MS.

Phenyl Thiocarbamate Derivatization
The determination of D or L configuration of the monomeric moieties was completed
through the creation of their aryl thiocarbamate derivatives followed by comparison of retention
times to corresponding standards using HPLC-UV analysis (30). In order to conserve the purified
oligosaccharides, this analysis was carried out using the parent fraction (SN-03) and an enriched
fraction known to contain both compounds (SN-03-Fr. 6). One mg and 23.7 mg of SN-03 Fr. 6
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and SN-03, respectively, were hydrolyzed in 2 M HCl for 60 min, with stirring, in an oil bath at
100 °C. The acid was removed from the samples either by repeated addition of H2O and
evaporation (SN-03-Fr. 6) or by the addition of Ag2CO3 (SN-03) and subsequent filtration to
remove AgCl. Before proceeding with derivatization, the hydrolyzed SN-03 sample was
extracted with EtOAc in an attempt to remove non-carbohydrate, colored compounds; however,
these remained in aq. solution but did not interfere with further reactions. L-cysteine methyl ester
(1-2 mg) and 100-200 µL of anhydrous pyridine (99%) was added to dried SN-03-Fr. 6 and SN03 as well as to the following standards individually (except SN-03, to which 5 mg and 500 µL
was added, respectively): D-(+)-glucose, L-(+)-arabinose, D-(-)-arabinose, L-(-)-xylose, D-(+)xylose, L-(+)-rhamnose, D-(+)-galactose, and D-(+)-mannose. Samples were incubated for 60
min at 60 °C in an oil bath with a reflux condenser and stirring, after which 100-200 µL of
phenyl isothiocyanate (10 mg/mL) in anhydrous pyridine was added and the samples incubated
for 60 min at 100 °C in an oil bath with stirring and reflux condensation. The cooled samples
were then analyzed by HPLC-UV.

HPLC-UV for D/L Determination
The liquid chromatographic system was a Waters 2695 Separations Module equipped
with a Waters 996 Photodiode Array detector (Waters Corporation, Milford, MA, USA). The
chromatographic conditions were as follows: stationary phase, Gemini C18 (4.6 x 250 mm, 110
Å, 5 µm); mobile phase, flow rate 1 mL/min; mobile phase gradient, H2O (0.1% formic acid):
MeCN (90:10) to MeCN over 45 min with a gradient curve of 6. A five min wash period with
MeCN and 15 min equilibration period was applied between each injection. The MaxPlot UV
absorbance and 210 nm absorbance was monitored. Each sample was injected twice to provide
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an average retention time for each peak. The injection volume of individual samples and
standards was 2 µL, while the injection volume of samples spiked with the standard was 3 µL.
An isocratic method with a mobile phase of 27% aq. MeCN was employed for samples spiked
with L-(-)-xylose.

MSD-TOF
Samples were analyzed using an Agilent HPLC 1100 series equipped with a diode array
detector and a time of flight mass detector (Model G1969A) in series (Agilent Technologies,
Palo Alto, CA, USA). The mass detector contains an electrospray ionization interface and was
controlled by Agilent software (Agilent MassHunter Work Station, A.02.01) with subsequent
data acquisition and processing by the AnalystTM QS software (Analyst, QS 1.1). Mass spectra
were acquired in both positive and negative ionization modes for 1, 2, and their permethylated
derivatives using a capillary voltage of 3000 V. The nebulizer carrier gas was N2 (30 psig) in
combination with a drying gas at a flow of 10 mL/min and temperature of 325 °C. Full scan
mass spectra were acquired from m/z 100-1500. All samples analyzed were dissolved in 1 mM
NaOH in 50% aq. MeOH.

UHPLC/QTOF-MS
UHPLC-MS/MS analysis was carried out using an Agilent LC-1200 Infinity Series
(1290) UHPLC system coupled to a QTOF-MS (Model #G6530A, Agilent Technologies, Palo
Alto, CA, USA). The solid phase was an Agilent Bonus RP18 (2.1 x 100 mm, 1.8 µm) and a
mobile phase gradient of 3% aq. MeOH to 100% MeOH was engaged over 5 min at 0.25
mL/min, after which MeOH was held for 3 min at the same flow rate. A five minute wash with
MeOH followed by an equilibration period of 3 min was completed between each run. The
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column temperature was set at 35 °C and the injection volumes ranged from 3-5 µL. TIC
chromatogram peaks were assigned according to the mass of the compounds. The conditions of
the QTOF-MS were as follows: ESI source with Jet Stream technology using a drying gas (N2) at
11.0 L/min and 250 °C; nebulizer, 35 psig, sheath gas at 10 mL/min and 325 °C; capillary, 3500
V; skimmer 65 V; Oct RF V, 750 V; fragmentor voltage, 100 V. The sample collision energy
was set to 65 V. The data acquisition and analysis were controlled by Agilent MassHunter
Acquisition Software Ver. A.02.00 and processed by MassHunter Qualitative Analysis software
Ver. B.02.00. The samples were analyzed in positive mode and spectra were acquired across the
range m/z 100-1700 with accurate mass measurement. The accurate mass measurements were
obtained through use of a reference ion correction using m/z 121.0509 (protonated purine) and
922.0098 [protonated hexakis(1H, 1H, 3H-tetrafluoropropoxy) phosphazine or HP-921]. The
reference solution was introduced into the ESI source using a T-junction with an Agilent Series
1200 isocratic pump (Agilent Technologies, Santa Clara, CA, USA) containing a 100:1 splitter
with a flow rate of 20 µL/min. All samples analyzed were dissolved in 1 mM NaOH in 50% aq.
MeOH.

GC-MS Analysis
Gas chromatography-mass spectrometry was completed using an Agilent Packard 6890
Series GC system coupled with a Hewlett Packard 5973 Mass Selective detector. The conditions
of operation for analysis of the AA and PMAA derivatives were as follows: Restek Rtx®-2330
30 m, 0.25 mm id, 0.2 μm film thickness (df) column; injector temperature of 250 °C, split ratio
of 20:1, helium as the carrier gas, and a mass scan mode from m/z 50-500. The temperature
program was set with an initial temperature at 80 °C for two min, a first ramp at 30 °C/min to a
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final temperature of 170 °C and a second ramp at 4 °C/min to a final temperature of 240 °C, after
which this temperature was held for 20 min. The injection volume was 5 µL and each injection
was repeated three times. The conditions of operation for analysis of the trimethylsilyl
derivatives were the same as above except for the following: Grace EC-1 30 m, 0.25 mm id, 0.2
µm df column and an injection volume of 1 µL. Data acquisition and analysis were completed
with Agilent ChemStation and MestreNova software (Mestrelab Research, Escondido, CA,
USA).

Quantification of Alditol Acetate Derivatives
In order to determine a relative molar quantity of each monomer in the oligosaccharides,
a six-point calibration curve was created using the averaged peak areas (PA) from three
injections of the standard (AAstd). The detector Response Factor (RF; slope of the linear
calibration curve) was used to calculate a Relative Response Factor (RRF) of each
monosaccharide standard (S) relative to the internal standard (IS), as shown below:

The concentration (C) of each monosaccharide moiety (S) in the oligosaccharide samples was
calculated using the corresponding standard monosaccharide RRF (e.g. the glucose RRF was
used to calculate the concentration of glucose in the oligosaccharide sample) with the following
formula:
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The concentration of each monomeric moiety in the oligosaccharide sample was used to
calculate a relative molar ratio of the monomers in the sample. The concentration of the hexose
moiety (glucose) was divided by its approximate molar mass (180) and, likewise, the pentose
moieties (arabinose and xylose) were divided by 150. The resulting values were compared to
determine the relative molar ratio of each monomeric moiety.

NMR Analysis
1D and 2D NMR experiments were performed on a Bruker Avance 400 MHz NMR
equipped with a 3 mm z-gradient 1H/13C dual-nucleus probe for sample 2 and on a Bruker 600
MHz NMR for sample 1. Purified samples were dissolved in deuterium oxide (99.99%)
purchased from Cambridge Isotope Laboratories (Andover, MA, USA). The following spectra
were collected for each sample 1H, 13C, COSY, HSQC, HMBC, H2BC, NOESY, TOCSY, and
HSQC-TOCSY. A phase-sensitive COSY experiment was carried out for compound 1 using a
pulse program with the optimized 90 degree pulse of 11µs and a relaxation time (d1) of 1 s.

β-D-glucopyranosyl-(1→4)-[α-D-xylopyranosyl-(1→6)]-β-D-glucopyranosyl-(1→4)-β-Dglucopyranosyl-(1→4)-[α-L-arabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-β-Dglucopyranose (1)
White amorphous powder; moderately hygroscopic; 1H NMR and 13C NMR data: see
Table 1.5 and Figure 1.16; MSD-TOF (negative ion mode) [M-H]- at m/z 1061.3121; ESIQTOF-MS of permethylated compound (positive ion mode) [M+Na]+ at m/z 1365.6545, see
Table 1.2.
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β-D-glucopyranosyl-(1→4)-[α-L-arabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-β-Dglucopyranosyl-(1→4)-β-D-glucopyranosyl-(1→4)-[α-L-arabinofuranosyl-(1→2)-α-Dxylopyranosyl-(1→6)]-β-D-glucopyranose (2)
White amorphous powder; moderately hygroscopic; 1H NMR and 13C NMR data: see
Table 1.6 and Figure 1.24; MSD-TOF (negative ion mode) [M-H]- at m/z 1193.2786; ESI-QTOFMS of permethylated compound (positive ion mode) [M+Na]+ at m/z 1525.7012, see Table 1.2.

1.3 Results and Discussion

The fractionation and isolation of cranberry products afforded two novel compounds (1
and 2, Figure 1.3) from the aqueous extract. Sequential fractionation and purification steps
included Sephadex LH-20 size exclusion chromatography and HPLC with a C18 stationary phase,
followed by a polyamine stationary phase for the final purification. The purity and carbohydrate
nature of the isolated compounds was confirmed in the 1D NMR spectra and derivatization
procedures ensued.

MS Analysis
Initial MSD-TOF spectra of the non-derivatized, purified oligosaccharides indicate the
molecular ion; however, it is not present as a major ion peak. In all cases, the molecular ion is
less than 50% of the relative intensity (data not shown). Further, compound 1 yields no
molecular ion in the positive ion mode. Permethylation of the oligosaccharides provides
confirmation of suspected molecular ion mass. Permethylated carbohydrates more readily form
metal adducts as shown for tetramethylglucose (31), in addition, sodium has one of the highest
affinities for oligosaccharides and sodium adducts produce increased fragmentation in tandem
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MS-MS analysis (31, 32). Samples were injected in a 1 mM NaOH solution to enhance metaladduct formation and hence the ability to detect molecular ions. While sodiated ions are present,
in this case, [M+NH4]+ ions are present at the highest intensity which has been observed for olive
pulp and other oligosaccharides (33, 34). Permethylated 1 elutes at 4.9 and 5.1 min and affords
strong [M+NH4]+ and [M+Na]+ molecular ions (m/z 1360.6652 and 1365.6263, respectively),
with [M+NH4]+ at 100% relative intensity in both eluted peaks (Figure 1.5). Permethylated 2
elutes at 5.2 and 5.4 min and affords the same type of molecular ions as permethylated 1 at m/z
1520.7398 and 1525.6988, respectively (Figure 1.5). It is likely that the appearance of two
elution peaks is a result of the presence of both α- and β-anomers of the permethylated
oligosaccharides. Additional ions at m/z 689.3450 and 769.3771 are apparent in the
permethylated 1 and 2 spectra and represent the doubly charged molecular ions; this indicates the
ability of the oligosaccharides to associate with two ammonium ions. This phenomenon is
reported to occur with other xylan oligosaccharides (33). A secondary goal of permethylation
and analysis by QTOF-MS is the investigation of molecular fragments to aid in identification of
the connectivity of the monomers. However, in this analysis, minimal fragmentation is observed.
Cancilla et al. (32) has shown an inverse correlation of degree of branching of oligosaccharides
to fragmentation and the high level of branching in these oligosaccharides contributes to the lack
of fragmentation observed. The exact masses of the oligosaccharides (Table 1.2) allow the
calculation of the molecular formula and the assessment of the quantity of pentose and hexose
sugar residues establishing the DP. Compound 1 contains four hexose and three pentose
moieties and compound 2 contains four hexose and four pentose moieties.
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Figure 1.5. ESI-QTOF-MS spectra of permethylated compounds 1 and 2.
[M+NH4]+

Compound 1

[M+Na]+

[M+NH4]+

Compound 2

[M+Na]+

Table 1.2. Exact mass, molecular formula, and DP of two oligosaccharides from cranberry.

Exact Mass
Molecular
Formula
Degree of
Polymerization

Compound
1

Compound 1Permethylated

Compound
2

Compound 2Permethylated

1062.34

1342.6616

1194.39

1502.73

C39H66O33

C59H106O33

C44H74O37

C66H118O37

7

7

8

8

Trimethylsilyl Derivatization
After obtaining the molecular formulae and DP, the identification of the sugar residues is
pursued. Trimethylsilyl (TMS) derivatives are analyzed by GC-MS and the resulting retention
times and fragmentation patterns in the MS spectra are compared to standard monosaccharide
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derivatives. This particular derivatization is beneficial in that any acidic or amino-sugar residues
are preserved. However, due to mutarotation during methanolysis of the oligosaccharide, each
glycosyl residue yields four configurational isomers, including both α- and β-anomers of the
furan and pyran rings. The TMS derivatives of 2 match the retention times of the major
configurational isomers of arabinose, xylose, and glucose standards, indicating that only neutral
glycosyl units are present (Figure 1.6). Owing to the similarity of NMR spectra, it is apparent
that neutral sugar residues are also present in 1 and that the alditol acetate (AA) derivatization
method, which is specific to neutral sugars, will better suit further analysis.

Figure 1.6. TIC chromatogram of trimethylsilyl derivatives of compound 2 from GC-MS
analysis indicating the retention time (RT) and glycosyl identity.

AA
The AA derivatives produce a single product for each type of monomeric moiety present
in a carbohydrate, therefore, this method of derivatization is better suited for quantification of the
monomers (Figure 1.2 A). AAs of 1 and 2 are created through hydrolysis of the monomers,
reduction to the alditol form, and O-acetylation of the hydroxy groups, which improves
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volatilization in GC-MS analysis. The reduction using NaBD4 provides an additional
informative fragment in the MS spectra to allow confirmation of pentose or hexose residues.
Indicative fragment pairs of pentose and hexose residues appear at m/z 290/291 and m/z 361/362,
respectively. The identities of the residues are confirmed by comparison of the retention times
and MS spectra to the corresponding standards (Table 1.3). Through use of an internal standard,
the molar ratio of the monomers in the compounds is established. By combining the information
gained through MS analysis and the ratio of monomers present in the compounds, the exact
number of each residue is identified as one arabinose, two xylose, and four glucose moieties in
compound 1 and two each of arabinose and xylose, and four glucose moieties in compound 2
(Figure 1.7).

Table 1.3 Alditol acetate analysis of compounds 1 and 2.
Monomeric
Moiety
Arabinose
Xylose
Glucose

RT of Standard
(min)
19.45
21.35
26.19

Compound 1
RT of Sample
Molar
(min)
Ratio
19.82
1
21.73
2
26.88
4
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Compound 2
RT of Sample
Molar
(min)
Ratio
19.90
1
21.80
1
27.06
2

Figure 1.7. TIC chromatograms of alditol acetate derivatives of compounds 1 and 2 indicating
the RT and glycosyl identity.

PMAA
The purpose of developing PMAA derivatives is to gain information about the ring size
and location of the linkage(s) within a single glycosyl residue. This analysis answers two
questions: 1) Is a particular monomeric moiety in the furanose or pyranose form? 2) How many
residues is that monomer connected to and through which carbon is(are) the glycosidic bond(s)
formed? The derivatization technique is similar to that of the AA preparation except that the
samples are first methylated. This results in alditols that retain methoxy groups in the positions
where free hydroxy groups exist in the original structure as shown in Figure 1.2 B with the
exception of the reducing anomeric carbon. Acetoxy groups are present in the positions that are
involved in either the linkage to an adjacent residue or in ring formation as highlighted by
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corresponding colored boxes in Figure 1.2 B. The positions of the methoxy and acetoxy groups
are determined by comparison of the relative retention times (RRT; relative to the internal
standard) to that of PMAA derivatives of monosaccharide standards in GC-MS analysis. This
comparison must be combined with the analysis of the fragmentation observed in the MS spectra
and identification of distinguishing mass fragments (35) due to the potential overlap of RRTs.
The monomeric moieties are described in more detail with the information gained from
this analysis (Table 1.4 and Figure 1.8). Each residue can be viewed as a puzzle piece containing
a different shape and connectivity. Compound 1 contains one terminal arabinofuranoside, one
terminal xylopyranoside, one 2-linked xylopyranoside, two 4- and 6-linked glucopyranosides,
one terminal glucopyranoside, and one 4-linked glucopyranoside (Figures 1.8 and 1.9).
Compound 2 contains two terminal arabinofuranosides, two 2-linked xylopyranosides, one
terminal glucopyranoside, two 4- and 6-linked glucopyranosides, and one 4-linked
glucopyranoside (Figures 1.8 and 1.10). The only residues that can definitively be placed in a
terminal, non-reducing position are those that only contain an acetoxy group in the anomeric
position. The residues listed above without the “terminal” denotation may or may not be linked
through the anomeric position, even though the derivatives of all of these residues yield an
acetoxy group in the anomeric position. This is a result of the replacement of a methoxy group
in the anomeric position with an acetoxy group during derivatization. Accordingly, the 2-linked
xylopyranoside may represent a xylopyranoside with two glycosidic linkages through C-1 and C2 or it may represent a xylopyranose with a single substitution at C-2. It is apparent that, while a
wealth of information is gained from this method, caution is necessary in the interpretation.
With the compilation of the data provided through derivatization and NMR analysis, steps can be
taken towards arranging the monomeric moieties in their appropriate order.
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Table 1.4. PMAA derivative analysis of compounds 1 and 2.
TIC RT

Distinguishing
Mass Fragments

118, 161, 162
11.05
a
117, 118, 161, 162
12.28
118, 161, 162, 205
13.95
117, 190
15.98
118, 233
18.38
118, 261
21.78
a
Only present in compound 1

Monomeric Moiety Identity
terminal arabinofuranoside
terminal xylopyranoside
terminal glucopyranoside
2-linked xylopyranoside
4-linked glucopyranoside
4, 6-linked glucopyranoside

Figure 1.8. PMAA derivatives from compounds 1 and 2.

*Only present in compound 1.
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Figure 1.9. TIC chromatogram of PMAA derivatives of compound 1 by GC-MS analysis
indicating RT and glycosyl ring size and linkage. Minor peaks are contaminates and most are
non-carbohydrate in nature based of analysis of MS fragmentation.

Figure 1.10. TIC chromatogram of PMAA derivatives of compound 2 by GC-MS analysis
indicating RT and glycosyl ring size and linkage. Minor peaks are contaminates and most are
non-carbohydrate in nature based of analysis of MS fragmentation.
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D/L Configuration
Determination of the absolute configuration of the monomeric moieties in a carbohydrate
is an essential aspect of understanding biological activity, as the presence of the enantiomer of a
single residue may have a significant effect on the activity of a glycan-containing molecule.
Through the reaction of L-cysteine methyl ester and phenyl isothiocyanate with hydrolyzed
carbohydrate residues, phenyl thiocarbamates are created and provide optically active
diastereomers of the enantiomeric carbohydrate reactants (Figure 1.2 C). These diastereomers
are then readily analyzed using commonly available HPLC-UV systems (30). In order to
conserve the purified oligosaccharide samples, two parent fractions containing both compounds
1 and 2 are included in the analysis, SN-03-Fr. 6 and SN-03. SN-03-Fr. 6 is a fraction enriched
for the two compounds, while SN-03 contains several other compounds. Through comparison of
retention times to standards (Figure 1.11) and spiking of the derivatized samples, the presence of
D-(-)-arabinose is

ruled out and the presence of D-(+)-glucose and D-(+)-xylose is confirmed.

The remaining peak eluting at 18.65 min in SN-03-Fr. 6 closely overlaps with both L-(+)arabinose and L-(-)-xylose standard RT (Figures 1.14 and 1.11). To provide definitive
identification, an altered isocratic elution method is employed in addition to spiking both
samples with L-(+)-arabinose and L-(+)-xylose on separate occasions (Figures 1.12 and 1.13).
With this approach, it is clear that this peak is L-(+)-arabinose; thereby confirming the presence
of a single enantiomer of each different sugar residue present in the oligosaccharides.
Compounds 1 and 2 are both composed of D-(+)-glucose, L-(+)-arabinose and D-(+)-xylose
(Figures 1.14 and 1.15).
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Figure 1.11. HPLC-UV chromatogram of phenyl thiocarbamate derivatives of monosaccharide
standards indicating RT.

Figure 1.12. HPLC-UV chromatogram of phenyl thiocarbamate derivatives of SN-03-Fr. 6
spiked with L-xylose indicating peak identity.
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Figure 1.13. HPLC-UV chromatogram of phenyl thiocarbamate derivatives of fraction SN-03
spiked with L-xylose indicating peak identity.

Figure 1.14. HPLC-UV chromatogram of the phenyl thiocarbamate of SN-03-Fr. 6 indicating
RT and peak identity.

Figure 1.15. HPLC-UV chromatogram of phenyl thiocarbamate derivatives of fraction SN-03
indicating RT and peak identity.
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NMR
The structural information gained from NMR experiments includes identification of the
configuration at the anomeric carbon and of the linkage between glycosyl residues. The ability
to confidently assign linkage of individual monomers relies upon the sound assignment of the
key carbons involved in the glycosidic linkage. This section describes the identification of
anomeric configuration of each monomer followed by the steps taken towards a full structural
assignment of these oligosaccharides, including the glycosidic linkages.
The 1H NMR spectrum of compound 1 contains eight proton signals in the anomeric
region at δ 4.38 (Glc-C), 4.42 (Glc-D), 4.43 (Glc-B), 4.53 (β-Glc-A), 4.83 (Xyl-F), 4.97 (Xyl-E),
5.04 (Ara-G), and 5.09 (α-Glc-A) (Figure 1.16, Table 1.5). The corresponding 13C NMR
chemical shifts to the anomeric protons presented in the HSQC spectrum (Figure 1.17) are δ
102.6, 102.51, 102.46, 95.68, 98.77, 98.56, 109.2, and 91.78, respectively. The reason for the
appearance of eight anomeric signals, despite the presence of seven glycosyl residues, is
attributable to the presence of one glycosyl residue (Glc-A) as both α- and β-anomers. In
general, anomeric signals with a relatively upfield chemical shift (e.g. > 4.70 ppm) are αanomers, while those with a relatively downfield chemical shift (e.g. < 4.70 ppm) are β-anomers
(36) and can therefore be assigned as such. In addition, the 3JH1,H2 values are used for further
support. The 3JH1,H2 coupling constant of glucose in a 4C1 conformation has a value in the range
of ca. 4-5 Hz for the α-anomers due to a relatively small dihedral angle between H-1 and H-2.
Likewise, for the β-anomers the value ranges from ca. 7-8 Hz due to a relatively larger dihedral
angle. The 3JH1,H2 of the glucose moieties of compound 1 are 7.13 Hz (Glc-C), 7.13 (Glc-D), 7.62
(Glc-B), 7.62 (β-Glc-A), and 3.63 (α-Glc-A). This indicates β-anomeric glucose moieties, with
the exception of Glc-A which, due to its reducing nature, undergoes mutarotation and hence is

33

present as both α- and β-anomers in solution. The 4C1 conformation of xylopyranose is similar to
that of glucose and hence the same rules can be applied. The 3JH1,H2 values for the xylose
residues are 2.74 and 3.32 Hz for Xyl-E and Xyl-F, respectively, which establishes the αanomeric form for both. The 3JH1,H2 value of Ara-G is 1.92 Hz indicating its α-anomeric nature
in agreement with published 3JH1,H2 values for α-L-arabinofuranosides (37, 38).
The remaining proton and carbon assignments are generated from the HSQC spectrum
and further clarified with additional 2D NMR experiments. Many of the methine carbons are
assigned using data provided by COSY and H2BC experiments (Figure 1.18). C-1 through C-3
and in some cases C-4 assignment is possible in this way for each glycosyl residue. The
crowding of correlations in the δ 3.10-3.85 region masks many correlations which one would
expect to observe. Although, Ara-G is fully elucidated with just these three 2D experiments, in
combination with 1H and 13C NMR spectra, because most of the chemical shifts of this
monosaccharide lie in less crowded regions. The HMBC spectrum provides further information
to allow assignment of remaining carbons with the exception of C-5 and C-6 of Glc-A and C-6
of Glc-C (Figure 1.19). The HSQC-TOCSY experiment reveals the involvement of a carbon in
the δ 79 region in the Glc-A ring system (Figures 1.20 and 1.16) and therefore allows the
assignment of the δ 79 resonance to C-4; however a corresponding proton signal cannot be
confirmed. The remaining C-6 resonances of Glc-A and Glc-C are known to have a similar
chemical shift, δ 66.28 and 66.08, based on the fact that these two methylene carbons are the
only two yet to be assigned. The position of both can be confirmed if a correlation is identified
with just one of these two proton-carbon pairs. The proton signal at δ 3.88 (dd) corresponding to
the carbon at δ 66.08 (Figure 1.16) is the optimal signal to pursue with a phase sensitive COSY
experiment. With this experiment, a correlation between C-5 (δ 3.62) and C-6 (δ 3.88) of Glc-C
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is identified (Figure 1.21), confirming the assignment of C-6 of Glc-C at δ 66.08 and C-6 of GlcA at δ 66.28. Full 2D NMR spectra for compound 1 are reported in Appendix A.
With the structural assignment of compound 1 confirmed, the linkage of the monomeric
moieties can be accurately assessed. The nature of the β-(1→4)-glucose backbone is determined
through comparison of NMR spectra with that of cellotetraose (Figure 1.22) as well as through
key NOESY correlations between H-3 (δ 3.52) of Glc-A and H-1 (δ 4.43) of Glc-B and between
H-3 (δ 3.54) of Glc-B and H-1 (δ 4.38) of Glc-C (Figure 1.23). As for the side chains, the
HMBC data (Figure 1.19) indicates a correlation between H-1 (δ 5.04) of Ara-G and C-2 (δ
78.78) of Xyl-E establishing a 1 → 2 linkage. The correlation between H-1 (δ 4.97) of Xyl-E
and C-6 (δ 66.28) of Glc-A and between H-1 (δ 4.83) of Xyl-F and C-6 (δ 66.08) of Glc-C
establishes a 1 → 6 linkage between the respective xylose and glucose residues. The assignment
of C-6 of Glc-A and Glc-C is integral in determining the location the Xyl-E-Ara-G and Xyl-F
side chains due to the attachment of each Xyl residues to one of the two methylene carbons at δ
66. Consequently, compound 1 is identified as the novel β-D-glucopyranosyl-(1→4)-[α-Dxylopyranosyl-(1→6)]-β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyl-(1→4)-[α-Larabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-β-D-glucopyranose.

35

Table 1.5. 1H and 13C NMR data for compound 1.
Compound 1
1
2
3
4
5
6
1
2
3
4
5
6
1
2
3
4
5
6

δ13C
95.68
73.81
74.32
69.97
79
66.28
91.78
71.15
73.21
69.97
66.28
102.46
72.7
74
69.44
79.17
60.04

4,6-linked Glcp-C

1
2
3
4
5
6

102.6
73.11
75.47
69.44
79.01
66.08

terminal Glcp-D

1
2
3
4
5
6

102.51
72.7
74
69.44
79.40
60.56

2-linked Xylf-E

1
2

98.56
78.78

Monomeric moiety
reducing Glcp-A
β-anomer
(4,6-linked)

reducing Glcp-A
α-anomer

4-linked Glcp-B

δ1H (J in Hz)
4.53 d (7.62)
3.16 t (9.39)
3.52
3.83
3.83
5.09 d (3.63)
3.41-3.43
3.71
3.83
3.83
4.43 d (7.62)
3.28 t (8.83)
3.54
3.29 t (9.19)
3.55
3.75,
3.64
4.38 d (7.13)
3.18 t (7.89)
3.36
3.29 t (9.19)
3.62
3.78
3.88 dd (11.04, 4.95)
4.42 d (7.13)
3.28 t (3.83)
3.54
3.53
3.62
3.79
3.70
4.97 d (2.74)
3.45
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terminal Xylf-F

terminal Araf-G

3
4
5
1
2
3
4
5
1
2
3
4
5

71.92
69.44
61.15
98.77
71.48
73.01
69.44
61.5
109.2
81.11
76.39
83.75
61.15

3.72
3.53
3.60-3.62
4.83 d (3.32)
3.41-3.43
3.59
3.43-3.44
5.04 s (1.92)
4.07
3.81
3.96 m
3.59
3.73
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Figure 1.16. 1H and 13C NMR spectra of compound 1. 1H NMR B) 600 MHz spectrum; A)
expanded anomeric region at 400 MHz; C) 13C NMR spectrum.

A

B

C
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Figure 1.17. HSQC spectrum of compound 1 highlighting the anomeric region correllations.
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Figure 1.18. COSY and key H2BC correlations of compound 1.
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Figure 1.19. Key HMBC correlations of compound 1.

Figure 1.20. Key TOCSY and HSQC-TOCSY correlations of compound 1.
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Figure 1.21. Phase sensitive COSY spectrum of compound 1 indicating a key correlation.

Figure 1.22. 1H and 13C NMR spectra of cellotetraose.
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Figure 1.23. NOESY correlations of compound 1.

The 1H NMR spectrum for compound 2 contains eight signals in the anomeric region,
similar to that of compound 1, with the major difference being the partial overlap of chemical
shifts of the two xylose residues. This partial overlap is attributable to the increased similarity of
the chemical environment of the residues, as compared to those in compound 1. The two
doublets merge to form a signal resembling a triplet; a single chemical shift is used to indicate
both xylose anomeric carbons because it is both unnecessary and unfeasible to distinguish
between the two in further structural assignment. The anomeric protons resonate at δ 4.43 (GlcC), 4.45 (Glc-D), 4.47 (Glc-B), 4.58 (β-Glc-A), 5.01 (Xyl- E and F), 5.09 (Ara-G and H), and
5.14 (α-Glc-A) (Table 1.6 and Figure 1.24). The corresponding 13C NMR signals are presented
in the HSQC spectrum (Figure 1.25) and resonate at: δ 102.5, 102.5, 102.5, 95.6, 98.5, 109.2,
and 91.7, respectively. As in compound 1, the reducing glucose (A) is present in both α- and β-
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anomers with the α-anomer carbon and proton resonating at δ 91.7 and δ 5.14 (3JH1,H2 3.90 Hz),
respectively, and the β-anomer carbon and proton resonating at δ 95.6 and δ 4.58 (3JH1,H2 7.99
Hz), respectively. The remaining glucose moieties are present as β-anomers as determined by
the 3JH1,H2 values of 8.21, 7.76, and 7.99 Hz for Glc-B, Glc-C, and Glc-D, respectively. The
3

JH1,H2 of 3.76 Hz for the two xylose moieties establishes these as α-anomers. The two Ara

moieties are also defined as α-anomers, as in compound 1, by a 3JH1,H2 value of 1.95 Hz.
The remaining protons and their respective carbons are identified using HSQC and the
structural assignment of most signals is completed with COSY, H2BC, and HMBC data (Figures
1.26 and 1.27). HMBC resonances are identified between monosaccharide residues establishing
the nature of the glycosidic linkages. The correlations between H-1 of Ara moieties (δ 5.09) and
C-2 of Xyl moieties (δ 78.7) confirm the arabinoside-(1→2)-xyloside linkage which is identical
to that observed in compound 1. The correlations between H-1 of Xyl moieties (δ 5.01) and C-6
of Glc-A and C (δ 66.3) also closely resemble the branching order in compound 1. Further 2D
NMR experiments are presented in Appendix B (TOCSY, HSQC-TOCSY, and NOESY),
however, no additional information is gained beyond that provided by the COSY, H2BC, and
HMBC experiments. While NOESY or HMBC did not provide correlations indicating glycosidic
linkage between glucose moieties, the β-(1→4)-glucose backbone was assigned as a result of the
similarity of spectra of compound 1, compound 2, and cellotetraose.
It should be noted that proton and carbon signals with little or no apparent correlations
were present in the data which suggest conformational flexibility of the oligosaccharide. The
methylene carbons resonating at δ 60.0 and 60.5 correlated with a larger than expected number
of protons in the HSQC spectrum (Table 1.6 and Figure 1.28) and all proton signals were
considered in assignment. Two carbon signals were present at δ 59.85 and 60.0 which were
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lumped together as the δ 60.0 signal. The presence of the two small carbon signals as well as the
larger than expected number of proton correlations reveals variation in chemical shift values
which may be a result of conformational changes. This change can be expected in such a large
molecule containing sp3 hybridized carbons. Further, the location of the C-6 resonances at δ
60.0 and 60.5 as oxymethylene tails surrounded by neighboring disaccharide side chains may
result in intramolecular interactions that influence electron shielding or deshielding of the
methylene groups. Another assignment in which shifting, likely as a result of conformational
change, is apparent is in C-3 of Glc-C. In this case, the vicinal C and H signals presented dual
correlations with the carbons at both δ 75.4 (H, δ 3.42) and 75.9 (H, 3.40) in COSY, H2BC, and
HMBC experiments (Figure 1.26). As a result, resonances at δ 75.4 and 75.9 are assigned to C-3
of Glc-C.
The NMR data for compound 2 contains a number of signals and correlations that are
determined to be insignificant for the structural assignment. For example, a large singlet at δ 3.27
correlating with a carbon signal at δ 48.8 in the HSQC spectrum is an impurity that appeared
subsequent to initial NMR examination. In addition, a doublet of doublets at δ 3.39 could not be
assigned in any 2D experiments except for a single correlation in the COSY data, and a small
group of correlations in the regions δC 78-79 and δH 3.49-3.59 are left inexplicable. Owing to the
knowledge of sample contamination and the potential for conformational shifting, the structural
assignment of compound 2 integrates reliable signals gained from the NMR data and chemical
shift information obtained for compound 1, resulting in the fully elucidated structure. This
establishes the structure of the novel octasaccharide 2 as β-D-glucopyranosyl-(1→4)-[α-Larabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-β-D-glucopyranosyl-(1→4)-β-D-
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glucopyranosyl-(1→4)-[α-L-arabinofuranosyl-(1→2)-α-D-xylopyranosyl-(1→6)]-β-Dglucopyranose.

Table 1.6. 1H and 13C NMR data for compound 2.

Monomeric moeity
reducing Glcp-A
β-configuration
(4,6-linked)

reducing Glcp-A
α-configuration
4,6-linked
4-linked Glcp-B

4,6-linked Glcp-C

terminal Glcp-D

2-linked Xylp-E

Compound 2
δ13C
1
95.6
2
73.52
3
74.25
4
69.9
5
79.2
6
66
1
91.7
2
71.2
3
73.5
4
69.9
1
102.5
2
72.63
3
73.93
4
69.36
5
79.4
6
60.0
1
102.5
2
73.04
3
75.39
3’ 75.90
4
69.36
5
78.9
6
66
1
102.5
2
72.63
3
73.93
4
69.36
5
79.5
6
60.5
1
98.5
2
78.7
3
71.8

δ1H (J in Hz)
4.58 d (7.99)
3.23
3.55
3.87
3.62
3.87
5.14 d (3.90)
3.51
3.23
3.87
4.47 d (8.21)
3.32
3.59
3.59
3.62
3.87, 3.83, 3.80, 3.72
4.43 d (7.76)
3.24
3.42
3.40
3.34
3.62
3.87 dd
4.45 d (7.99)
3.32
3.59
3.34
3.62
3.84-5, 3.77
5.01 d (3.76)
3.49
3.78
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2-linked Xylp-F

terminal Araf-G

terminal Araf-H

4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5

69.36
61.1
98.5
78.7
71.8
69.36
61.1
109.1
81.0
76.3
83.7
61.1
109.1
81.0
76.3
83.7
61.1

3.59
3.66, 3.76
5.01 d (3.76)
3.49
3.78
3.59
3.66, 3.76
5.09 s (1.95)
4.12 dd (3.78, 1.57)
3.86
4.00 m
3.64, 3.76
5.09 s (1.95)
4.12 dd (3.78, 1.57)
3.86
4.00 m
3.64, 3.76
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Figure 1.24. 1H and 13C NMR DEPT spectra of compound 2.
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Figure 1.25. HSQC spectrum of compound 2 indicating anomeric correlations.
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Figure 1.26. COSY and key H2BC correlations of compound 2.
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Figure 1.27. Key HMBC correlations of compound 2.

Figure 1.28. HSQC of compound 2 focusing on the oxymethylene C and H signals.
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The structure elucidation presented herein provides detailed structural characteristics of
two novel oligosaccharides from cranberry. This is the first presentation of a thorough
elucidation of oligosaccharides of this size and nature from plant sources. Oligosaccharides
isolated from wine (Grignolino and Chardonnay) of similar structure have been suggested,
however the extent of analysis did not provide confirmed structures (20). The structural
similarity lies in the substituted tetraglycosyl backbone, however, the side chain locations and
glycosyl composition are inconsistent with that presented here. Not one single method for
structure elucidation of carbohydrates, for example, ESI-QTOF-MS or NMR alone, can fully
describe each complexity of a compound class blessed with enormous potential for variety. The
dynamic structure elucidation scheme presented herein provides a model to guide further
investigation into complex oligosaccharide structures. In addition, the presentation of these
novel compounds invites future investigation into biological activity. The relatively small
degree of polymerization and molecular stability make these compounds potential candidates for
prebiotic and anti-adhesion activities.
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CHAPTER 2
BIOACTIVITY OF CRANBERRY OLIGOSACCHARIDES
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2.1 Introduction
As seen in the first chapter, oligosaccharides have the potential to offer many benefits to
human health including benefits to the immune system (3, 17), the gastrointestinal tract by
providing a prebiotic effect (4), and the potential for use in the treatment and prevention of
microbial infections (2). In addition, cranberry products have shown antimicrobial activity and
antiviral activity. An extensive study against various foodborne bacterial pathogens indicates the
importance of a water soluble phenolic extract in the inhibition of growth of several pathogens
including two strains of Escherichia coli, Staphylococcus aureus, Listeria monocytogenes, and
Pseudomonas aeruginosa (9). Antiviral activity includes inhibition of the influenza virus by a
high molecular weight fraction of cranberry non-dialyzable material (10) and inhibition of
norovirus by cranberry proanthocyanidins (39). Further, cranberry extracts are being assessed
for anticancer effects and have been shown to be effective against several cancer cell types,
including ovarian, prostate, colon, and neuroblastoma cancers (6-8, 40). The most studied
fractions of cranberry assessed for anticancer activity are phenolic fractions (6, 8) and, more
specifically, proanthocyanidin extracts (7, 40). Likewise, both antimicrobial and anticancer
studies have focused on phenolic extracts from cranberry products leaving a void of information
regarding cranberry carbohydrate biological activity.
In addition to recent evidence of antimicrobial and anticancer properties, cranberries are
widely known for their traditional use in the treatment and prevention of urinary tract infections
(UTIs) (41, 42). Although the true efficacy of the consumption of cranberry products to aid in
the prevention of UTIs has been in question due to heterogeneity in clinical trials and patient
populations (43), recent reviews of clinical trials support the efficacy in young and middle-aged
women (11, 42). The pathogenesis of urinary tract bacterial infection is well understood,
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especially for infections caused by E. coli, which is the causative pathogen of more than 80% of
UTIs in young and adult women (44). Infection begins with the adhesion of bacteria to the
epithelial cells lining the urinary tract. Adhesion is followed by biofilm formation and invasion
into the uroepithelial cells (44). The site of attachment to uroepithelial cells has been identified
for several strains of E. coli, including Type 1 which binds to the Manα3Manα6Man moiety of
glycoproteins on the cell surface and P-fimbriated E. coli which binds to the Galα4Gal moiety of
glycolipids on cell surfaces (2). While Type 1 fimbriae can be inhibited by a number of natural
products or synthesized compounds containing D-mannose (2), cranberry products exhibit a
unique effectiveness against the adhesion of P-fimbriated E. coli (12, 45). The effectiveness of
cranberry products in the treatment of P-fimbriated E. coli UTIs has been assessed extensively
with in vitro assays using cranberry juice cocktail (45), cranberry extracts (14, 46, 47), and urine
collected from individuals after consumption of cranberry juice (13, 48, 49).

Figure 2.1. Chemical structure of quercitin, myricetin, and an A-type proanthocyanidin.
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Chemical investigation of cranberry products has afforded bioactive compounds that
exhibit an anti-adhesive effect against P-fimbriated E. coli. These compounds include A-type
proanthocyanidins (PACs, Figure 2.1), which have been hailed as a unique and highly active
group of polymers (14, 50), and other putatively active flavonoids (51). While it is reported that
PACs are the most important compounds in cranberry that possess this bioactivity against
bacterial UTIs, an even more important question is whether these compounds reach the urinary
tract in their native form. As of yet, it has been difficult to identify non-metabolized phenolic
cranberry compounds, such as myricetin and its isomer quercetin (Figure 2.1), in human urine.
However, metabolites of phenolic compounds are readily identifiable (52). Recent work has
established the tentative presence of myricetin and quercetin analogues in urine; albeit at low
concentrations that may not be effective in the prevention or treatment of UTIs (53). This further
implies the rarity of high molecular weight phenolic compounds, such as PACs, reaching the
bladder in their native form. Previous work by Christina M. Coleman in this laboratory has
revealed the presence of a putative bioactive oligosaccharide-containing fraction from pig urine,
collected after the consumption of spray-dried cranberry juice powder (unpublished data). The
chromatographic profile of this fraction closely resembles the chromatographic profile of the
parent fraction (SN-03) to the oligosaccharides presented in this work (Figure 2.2). While this
fraction could not be purified to its major constituents, NMR analysis suggests the presence of
compound 2 as well as other oligosaccharides and phenolic compounds (unpublished data).
Synthesized oligosaccharides, such as galabiose and derivatives of galabiose have been shown to
possess anti-adhesive activity (54) which calls into question the potential bioactivity of
compounds 1 and 2 as well as oligosaccharide fractions from cranberry in the prevention of
adhesion of E. coli to uroepithelial cells.
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Figure 2.2. HPLC-ESLD chromatograms of SN-03 (A) and an oligosaccharide-enriched fraction
(B) from pig urine collected after spray-dried cranberry juice consumption. Chromatographic
conditions: Waters Delta Prep 4000 and 2487 Dual Wavelength UV and PL-1000 ELS detectors
in series. Stationary phase: Atlantis dC18 (19 x 250 mm, 10 µm); mobile phase: (A) 0-10 min
H2O, 10-50 min H2O to 70% aq. MeOH; (B) 0-5 min H2O, 5-35 min H2O to 70% aq. MeOH.
The different gradient times result in different retention times of the peaks.

A

B

The research herein presents an analysis of the bioactivity of cranberry oligosaccharide
fractions and compounds 1 and 2 (Figure 1.3). The contribution of cranberry oligosaccharides to
antimicrobial activity is assessed as well as anticancer activity. Finally, an in vitro assay
utilizing radio-labeled P-fimbriated E. coli and uroepithelial cells is used to assess anti-adhesion
activity.
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2.2 Experimental Methods

Antimicrobial Assay
This assay was completed in the antimicrobial screening program available at the
National Center for Natural Products Research (NCNPR) according to previously reported
methods (55, 56) which have been modified from the Clinical and Laboratory Standards Institute
(CLSI) methods, formerly the National Committee for Clinical and Laboratory Standards
(NCCLS) (57-60). Cranberry samples were tested against a panel of 10 pathogenic organisms;
five of which were fungi (Candida albicans ATCC 90028, C. glabrata ATCC 90030, C. krusei
ATCC 6258, Cryptococcus neoformans ATCC 90113, and Aspergillus fumigates ATCC 204305)
and five of which were bacteria (Staphylococcus aureus ATCC 29213, methicillin-resistant
Staph aureus ATCC 33591, Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC
27853, and Mycobacterium intracellulare ATCC 23068). The inhibition of growth of each
organism by compound 2 was assessed at 20, 4, and 0.8 µg/mL and the IC50 was calculated using
XLFit curve fitting software. The IC50 of SN-03 was calculated in the same manner using test
concentrations of 200, 40, and 8 µg/mL. The IC50 represents the concentration (µg/mL) at which
50% inhibition of the organism is exhibited relative to positive and negative controls.

Breast Cancer Cell Viability Assay
Breast cancer cells T47D and MDA-MB-231 were seeded into a 96 well culture plate at
30,000 cells per well and incubated at 37 °C for 24 hrs in 200 µL of 10% FBS DMEM/F12
medium supplemented with 50 µg/mL penicillin/streptomycin. Compounds 1 and 2 (100 µL)
were added into separate wells at 10, 30, and 100 µM concentrations and fraction SN-03 was
added at 30 and 100 ppm and samples were tested in triplicate. Chlorahexamide (CHX; 100 µL,
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10 µM) was used as a positive control in addition to a media control. The cultures were
incubated at 37 °C for 48 hr under normoxic conditions. The cells were fixed with 10%
trichloroacetic acid (TCA) for 1 hr at 4 °C and washed four times with H2O then allowed to air
dry. Sulforhodamine B (0.4%) in 1% HOAc was added and allowed to sit for 15 min at room
temperature. The culture wells were washed four times with 1% HOAc and allowed to air dry.
Tris (200 µL, 10 mM) was added and the plates were placed on a rotary table for 5 min and
vortexed. Plates were read at 490/690 nm on a microplate reader. Percent inhibition was
calculated as:

Where

is the average absorbance of the triplicate wells incubated with a sample and

is

the average absorbance of the triplicate media control wells.

Escherichia coli-Uroepithelial (EC-UEC) Cell Anti-adhesion Assay
The EC-UEC anti-adhesion assay was recently developed in the laboratory of Dr. Boon
Chew at Washington State University and a publication detailing the method is not available.
Briefly, the procedure is as follows: human uroepithelial cells (UEC; HTB-4) were seeded at
1x105 cells per well in a 96 well culture plate and rinsed with PBS. P-fimbriated E. coli (ATCC
700928) were subcultured in colony forming antigen (CFA) agar to promote expression of Pfimbriae (61) and incubated for 4 hr at 35 °C with [3H]-uridine. The cells were rinsed with
phosphate buffered saline (PBS) and incubated with cranberry samples for 30 min at 35 °C.
[3H]-E. coli and UECs were incubated together in a ratio of 400:1, respectively, for 1 hr at 37 °C
and washed with PBS. Radioactivity of the wells was measured by liquid scintillation. Each
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sample was tested in duplicate in addition to a media control, solvent control, and two positive
controls (myricetin and A-type proanthocyanidin enriched cranberry extract). Inhibition curves
were collected with four concentration points that resulted in serial dilutions of the highest
concentration attainable, which varied depending on sample availability. IC50 was calculated for
positive controls but was unattainable for cranberry samples.

2.3 Results and Discussion

Antimicrobial Assay
Compound 2 and fraction SN-03 are both ineffective at inhibiting growth of 10
pathogenic micro-organisms, five fungi and five bacteria, as shown in the NCNPR antimicrobial
screen (Table 2.1). The lack of antimicrobial activity supports a mechanism of microbial disease
prevention or treatment that involves non-cytotoxic effects, such as anti-adhesion. It is important
to assess several mechanisms of microbial inhibition when determining the mechanism with
which a compound is involved. Other compounds present in cranberry, such as phenolic
compounds and proanthocyanidins possess antimicrobial activity, irrespective of anti-adhesion
activity, at µg concentrations (9) and this effect may confound results in an anti-adhesion assay.
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Table 2.1. IC50 of compound 2, fraction SN-03, and control against five fungal and five bacterial
pathogenic species.
Organism
Compound 2
SN-03
Amp Ba
Ciprob
Candida albicans
NAc
NA
1.20
NDd
C. glabrata
NA
NA
0.71
ND
C. kresei
NA
NA
1.18
ND
Aspergillus fumigatus
NA
NA
1.17
ND
Cryptococcus neoformans
NA
NA
0.31
ND
Staphylococcus aureus
NA
NA
ND
0.09
MRSAe
NA
NA
ND
0.07
Escherichia coli
NA
NA
ND
0.00
Pseudomonas aeruginosis
NA
NA
ND
0.06
Mycobacterium intracellulare
NA
NA
ND
0.33
a
b
Amphotericin B, positive control for fungal pathogens; Ciprofloxacin, positive control for
bacterial pathogens; c Not active; d Not determined; e Methicillin-resistant Staph aureus

Breast Cancer Cell Viability Assay
A cell viability assay using two breast cancer cell types (T47D and MDA-MB-231)
facilitates assessment of the anticancer activities of compounds 1 and 2 and fraction SN-03.
Anti-proliferative effects against two colon cancer cell lines are observed with treatment of
cranberry phenolic extracts (8). PACs also seem to be important in anti-proliferative activity
against different cancer cell lines as well as human umbilical vein endothelial cells (HUVECs)
(7, 40). However, the pure oligosaccharides and enriched fractions do not possess cytotoxic
effects against the two breast cancer cell lines (Table 2.2). The majority of biological assays of
cranberry are focused on phenolic extracts, however, assessing cranberry extracts of a different
chemical class, such as carbohydrates, provides a more thorough understanding of potential
bioactivity. This preliminary data suggests that the anti-proliferative effects of cranberry extracts
against both a variety of cancer cell types and HUVECs are a result of phenolic compounds
rather than carbohydrates.
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Table 2.2. Percent inhibition of breast cancer cell viability (T47D and MDA-MB-231) in
normoxic conditions by compounds 1 and 2, and fraction SN-03.
T-47D

% Inhibition (SE)
10 µm
-3 (± 4)
-3 (± 3)

Compound 1
Compound 2
SN-03
MDA-MB-231
0 (± 1)
Compound 1
-2 (± 2)
Compound 2
SN-03
a
Tested at 30 ppm; b Tested at 100 ppm

% Inhibition (SE)
30 µm
-6 (± 4)
-6 (± 11)
5a (± 3)

% Inhibition (SE)
100µm
-1 (± 4)
-4 (± 4)
2b (± 3)

-1 (± 2)
-3 (± 1)
0 (± 2)

-4 (± 4)
1 (± 2)
1 (± 2)

EC-UEC Anti-adhesion Assay
This assay is under development and is performed at Washington State University by Dr.
Boon Chew. The method involves radio-labeling P-fimbriated E. coli using [3H]-uridine, which
is incorporated into the RNA of the bacterial cells. A similar method of labeling DNA with [3H]thymidine shows the effectiveness of radio-labeling as a method to quantify bacteria and
bacterial growth (62). The radio-labeled, washed E. coli cells are first incubated with the sample
and the mixture is transferred to the UEC wells and incubated a second time to allow adhesion of
the E. coli to the UECs, similar to a previously described method using unlabeled E. coli (51).
Any bacterial cells that do not adhere to the UECs are washed away, leaving behind adhered,
radio-labeled E. coli cells which are then quantified by liquid scintillation. Considering that this
assay is still under development, it would be helpful to first address the issues that arose in the
testing of this cranberry sample set. First, the intention of the assay was to develop a six point
IC50 curve in which a single IC50 would be calculated for each sample to allow comparison
between samples. A complete inhibition curve is attained for myricetin, the positive control,
however, cranberry samples did not reach maximum inhibition due to a limitation of sample
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quantity and hence a less than optimal maximum concentration. This limitation prevents the
calculation of the IC50 and consequently limits a quantitative comparison between samples.
Second, due to the variation in sample matrix, the range of measured radioactivity (counts per
minute, cpm) varies from sample to sample; for example, myricetin ranges from ~6200 to 4300
cpm while aq. SN ranges from ~12000 to 2000 cpm. This variation also limits the ability to
compare activity between two samples and the ability to compare samples to the solvent control
(4383 cpm). Despite the problems presented, a classification of active or not active can be
assigned to each sample based on the shape of the dose response curves. Samples with an
overall negative slope (e.g. Figures 2.3 C, D) are considered active and samples with an overall
positive slope (e.g. Figure 2.4 A) are considered inactive. Samples in which the overall slope is
questionable (e.g. Figures 2.4 B, C) are considered potentially active in the sense that a negative
slope appears at higher concentrations and if samples could be tested at higher concentrations
than were reached in the data presented then increased anti-adhesion is possible.
The aq. SN extract, and fractions SN-03 and SN-04 that result from it, exhibit a dose
dependent anti-adhesive effect as seen by the decrease in radioactivity which parallels a
decreased number of E. coli adhered to UECs (Figures 2.3 A, B, C). The slope of the dose
response curves of SN-03 and SN-04 resemble that of the positive control, myricetin (Figure 2.3
D) and are thus considered active in their ability to prevent adhesion of E. coli to UECs.

A

qualitative assessment of the curves suggests an enhanced anti-adhesive effect of aq. SN due to
the increased slope of the curve and lower final level of radioactivity. This result may be a
combination of anti-adhesion and antimicrobial activity of the sample, as cranberry juice
fractions have been shown to possess antimicrobial activity, specifically, against E. coli.
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Figure 2.3. Dose response curves of aq. SN (A), SN-03 (B), SN-04 (C), and myricetin (D) in the
EC-UEC anti-adhesion assay.
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The fractionation of SN-03 yields three fractions containing compounds 1 and 2. SN-03-Fr.
4 contains compound 1 as its major constituent and SN-03-Fr. 5 contains compound 2 as its
major constituent. SN-03-Fr.6 contains both compounds 1 and 2 in addition to other minor
constituents. Anti-adhesive activity appears to be lost in these fractions (Figure 2.4 A, B, C) as
compared to the parent fraction. This lack of activity is also exhibited in purified 1 and 2 from
SN-03-Fr. 4 and 5, respectively (Figure 2.5 A, B).
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Figure 2.4. Dose response curves of SN-03-Fr. 4 (A), Fr. 5 (B), and Fr. 6 (C) in the EC-UEC
anti-adhesion assay.
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Figure 2.5. Dose response curves of compounds 1 (A) and 2 (B) in the EC-UEC anti-adhesion
assay.
15000

15000

B

12000

12000

9000

9000

cpm

cpm

A

6000
3000

6000
3000

0

0
0

2

4

6

8

10

0

Concentration (mg/mL)

2

4

6

8

10

Concentration (mg/mL)

The progressive lack of anti-adhesive activity in the purification of compounds 1 and 2
from the parent fractions indicates that the oligosaccharides alone may not be the source of the
bioactivity. Being that compounds 1 and 2 are present in the highest quantity in the active SN-03
fraction, one would assume their involvement in the bioactivity. It is possible that another
compound is present in the SN-03 fraction that is solely responsible for the bioactivity, however,
upon investigation of the bioactivity of the remaining SN-03 fractions (Figures 2.6 A, B, C, D,
E) this is unlikely. SN-03-Fr.2 was not assayed due to sample limitation; this fraction was
collected over a time period in which no chromatographic peaks eluted. All of the bioassayed
fractions collected from SN-03 have similar dose response curves suggesting that a single
compound does not stand out above the others in terms of bioactivity. Fractions 5, 6 (Figures 2.4
B, C) and 9 (Figure 2.6 E) exhibit curves with a negative slope above a test concentration of 7
mg/mL. It is possible that the concentrations that were examined are not high enough to exhibit
activity and if these fractions were tested at higher concentrations, bioactivity may be seen.
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Figure 2.6. Dose response curves of SN-03-Fractions 1 (A), 3 (B), 7 (C), 8 (D), and 9 (E) in the
EC-UEC anti-adhesion assay.
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A synergistic interaction between the compounds present in SN-03 is also important to
consider. The low resolution of the major chromatographic peaks in SN-03 (Figure 1.4) suggest
several compounds of similar composition; that is, several oligosaccharides constitute this
fraction. The phenyl thiocarbamate analysis described in Chapter 1 reveals that four
monosaccharides (Ara, Glc, Xyl, and Gal; Figure 1.15) are present in SN-03 after hydrolysis, of
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which only three were identified in the purified compounds. In addition, a simple anthocyanidin
test on SN-03 indicates the presence of a small amount of proanthocyanidin-type compound(s)
(data not shown). This is also apparent in the lavender-maroon color of the dried SN-03 fraction,
the color which eluted in SN-03-Fr. 9. Interactions have been shown to occur between
proanthocyanidins, or other polyphenolic compounds, and carbohydrates (63, 64). The potential
interaction between oligosaccharides present in this fraction with proanthocyanidin-type
compounds may have a synergistic effect on the anti-adhesive activity of the fraction. NMR
studies of purified oligosaccharides and purified compounds from fraction 9 would be helpful in
elucidating potential interactions.
In order to fully understand the anti-adhesive bioactivity of the oligosaccharides in
cranberry, continued isolation and analysis are necessary. Bioassay of higher concentrations of
the purified compounds and fractions would confirm the presence of bioactivity, especially in
SN-03-Fr. 5, 6, and 9. In addition, testing the fractions of SN-03 in different combinations may
reveal a synergy or combined anti-adhesive effect that matches the activity of the parent fraction.
For example, the combination and subsequent bioassay of SN-03-Fr. 5 and 9 may exhibit
bioactivity.
In conclusion, the oligosaccharide-enriched fraction, SN-03, and the aq. SN extract are
confirmed to possess anti-adhesive activity, inhibiting the adhesion of P-fimbriated E. coli to
uroepithelial cells. Continued bioassay of SN-03 fractions will confirm the nature of antiadhesion activity of the parent fraction which may be a result of synergistic interaction of the
constituents. A lack of antimicrobial activity of SN-03 further supports the anti-adhesive activity
by ruling out a cytotoxic effect on the bacterial cells. In addition, the absence of both
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antimicrobial and anticancer activity of these oligosaccharide rich fractions and pure compounds
indicate that free carbohydrates are not likely involved in this type of bioactivity.

69

LIST OF REFERENCES

70

1.
Bertozzi, C. R.; Kiessling, L. L., Chemical glycobiology. Science (Washington, DC, U. S.) 2001,
291, 2357-2364.
2.
Sharon, N., Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim.
Biophys. Acta, Gen. Subj. 2006, 1760, 527-537.
3.
Clement, M.-J.; Tissot, B.; Chevolot, L.; Adjadj, E.; Du, Y.; Curmi, P. A.; Daniel, R., NMR
characterization and molecular modeling of fucoidan showing the importance of oligosaccharide
branching in its anticomplementary activity. Glycobiology 2010, 20, 883-894.
4.
Roberfroid, M.; Gibson, G. R.; Hoyles, L.; McCartney, A. L.; Rastall, R.; Rowland, I.; Wolvers,
D.; Watzl, B.; Szajewska, H.; Stahl, B.; Guarner, F.; Respondek, F.; Whelan, K.; Coxam, V.; Davicco,
M.-J.; Leotoing, L.; Wittrant, Y.; Delzenne, N. M.; Cani, P. D.; Neyrinck, A. M.; Meheust, A., Prebiotic
effects: metabolic and health benefits. Br. J. Nutr. 2010, 104, S1-S63.
5.
Zheng, W.; Wang, S. Y., Oxygen Radical Absorbing Capacity of Phenolics in Blueberries,
Cranberries, Chokeberries, and Lingonberries. J. Agric. Food Chem. 2003, 51, 502-509.
6.
Babich, H.; Ickow, I. M.; Weisburg, J. H.; Zuckerbraun, H. L.; Schuck, A. G., Cranberry juice
extract, a mild prooxidant with cytotoxic properties independent of reactive oxygen species. Phytother.
Res. 2012, 26, 1358-65.
7.
Singh, A. P.; Lange, T. S.; Kim, K. K.; Brard, L.; Horan, T.; Moore, R. G.; Vorsa, N.; Singh, R.
K., Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation,
cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cells. Int. J. Oncol. 2012, 40, 99108.
8.
Vu, K. D.; Carlettini, H.; Bouvet, J.; Cote, J.; Doyon, G.; Sylvain, J.-F.; Lacroix, M., Effect of
different cranberry extracts and juices during cranberry juice processing on the antiproliferative activity
against two colon cancer cell lines. Food Chem. 2012, 132, 959-967.
9.
Cote, J.; Caillet, S.; Doyon, G.; Dussault, D.; Sylvain, J. F.; Lacroix, M., Antimicrobial effect of
cranberry juice and extracts. Food Control 2011, 22, 1413-1418.
10.
Oiknine-Djian, E.; Houri-Haddad, Y.; Weiss, E. I.; Ofek, I.; Greenbaum, E.; Hartshorn, K.;
Zakay-Rones, Z., High molecular weight constituents of cranberry interfere with influenza virus
neuraminidase activity in vitro. Planta Med. 2012, 78, 962-967.
11.
Wang C, F. C. C. N.; et al., Cranberry-containing products for prevention of urinary tract
infections in susceptible populations: A systematic review and meta-analysis of randomized controlled
trials. Arch. Int. Med. 2012, 172, 988-996.
12.
Ofek, I.; Goldhar, J.; Zafriri, D.; Lis, H.; Adar, R.; Sharon, N., Anti-Escherichia coli adhesin
activity of cranberry and blueberry juices. N. Engl. J. Med. 1991, 324, 1599.
13.
Howell, A. B.; Botto, H.; Combescure, C.; Blanc-Potard, A. B.; Gausa, L.; Matsumoto, T.;
Tenke, P.; Sotto, A.; Lavigne, J. P., Dosage effect on uropathogenic Escherichia coli anti-adhesion
activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a
multicentric randomized double blind study. BMC Inf. Dis. 2010, 10, 94.

71

14.
Foo, L. Y.; Lu, Y.; Howell, A. B.; Vorsa, N., A-type proanthocyanidin trimers from cranberry
that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J. Nat. Prod. 2000, 63, 1225-1228.
15.

Zaia, J., At last, functional glycomics. Nat. Methods 2011, 8, 55-57.

16.

Zopf, D.; Roth, S., Oligosaccharide anti-infective agents. Lancet 1996, 347, 1017-21.

17.
Satitmanwiwat, S.; Ratanakhanokchai, K.; Laohakunjit, N.; Chao, L. K.; Chen, S.-T.; Pason, P.;
Tachaapaikoon, C.; Kyu, K. L., Improved purity and immunostimulatory activity of β-(1→3)(1→6)glucan from Pleurotus sajor-caju using cell wall-degrading enzymes. J. Agric. Food Chem. 2012, 60,
5423-5430.
18.
Pollet, A.; Van, C. V.; Van, d. W. T.; Verstraete, W.; Delcour, J. A.; Courtin, C. M., In vitro
fermentation of arabinoxylan oligosaccharides and low molecular mass arabinoxylans with different
structural properties from wheat (Triticum aestivum L.) bran and psyllium (Plantago ovata Forsk) seed
husk. J. Agric. Food Chem. 2012, 60, 946-954.
19.
Polari, L.; Ojansivu, P.; Makela, S.; Eckerman, C.; Holmbom, B.; Salminen, S.,
Galactoglucomannan Extracted from Spruce (Picea abies) as a Carbohydrate Source for Probiotic
Bacteria. J. Agric. Food Chem. 2012, 60, 11037-11043.
20.
Bordiga, M.; Travaglia, F.; Meyrand, M.; German, J. B.; Lebrilla, C. B.; Coisson, J. D.; Arlorio,
M.; Barile, D., Identification and characterization of complex bioactive oligosaccharides in white and red
wine by a combination of mass spectrometry and gas chromatography. J. Agric. Food Chem. 2012, 60,
3700-3707.
21.
Li, B. W., Analysis of dietary fiber and nondigestible carbohydrates. In Handbook of Prebiotics
and Probiotics Ingredients: Health Benefits and Food Applications, Cho, S. S. F., E. Terry, Ed. CRC
Press: Boca Raton, FL, 2010; pp 1-12.
22.
Abe, T.; Horiuchi, K.; Kikuchi, H.; Aritsuka, T.; Takata, Y.; Fukushi, E.; Fukushi, Y.; Kawabata,
J.; Ueno, K.; Onodera, S.; Shiomi, N., Structural confirmation of oligosaccharides newly isolated from
sugar beet molasses. Chem. Cent. J. 2012, 6, 89.
23.
Hakomori, S., Rapid permethylation of glycolipids and polysaccharides, catalyzed by
methylsulfinyl carbanion in dimethyl sulfoxide. J. Biochem. 1964, 55, 205-8.
24.
Ciucanu, I.; Kerek, F., A simple and rapid method for the permethylation of carbohydrates.
Carbohydr. Res. 1984, 131, 209-17.
25.
Clamp, J. R.; Bhatti, T.; Chambers, R. E., The determination of carbohydrate in biological
materials by gas-liquid chromatography. Methods Biochem. Anal. 1971, 19, 229-344.
26.
DeJongh, D. C.; Radford, T.; Hribar, J. D.; Hanessian, S.; Bieber, M.; Dawson, G.; Sweeley, C.
C., Analysis of trimethylsilyl derivatives of carbohydrates by gas chromatography and mass spectrometry.
J. Amer. Chem. Soc. 1969, 91, 1728-40.
27.
Duus, J. O.; Gotfredsen, C. H.; Bock, K., Carbohydrate structural determination by NMR
spectroscopy: modern methods and limitations. Chem. Rev. (Washington, D. C.) 2000, 100, 4589-4614.

72

28.
Azadi, P., Course Materials: Techniques for characterization of carbohydrate structure of
polysaccharides. In Complex Carbohydrate Research Center, University of Georgia: Athens, GA, 2011.
29.
Doares, S. H.; Albersheim, P.; Darvill, A. G., An improved method for the preparation of
standards for glycosyl-linkage analysis of complex carbohydrates. Carbohydr. Res. 1991, 210, 311-17.
30.
Tanaka, T.; Nakashima, T.; Ueda, T.; Tomii, K.; Kouno, I., Facile discrimination of aldose
enantiomers by reversed-phase HPLC. Chem. Pharm. Bull. 2007, 55, 899-901.
31.
Botek, E.; Debrun, J. L.; Hakim, B.; Morin-Allory, L., Attachment of alkali cations on β-Dglucopyranose: matrix-assisted laser desorption/ionization time-of-flight studies and ab initio calculations.
Rapid Commun. Mass Spectrom. 2001, 15, 273-276.
32.
Cancilla, M. T.; Penn, S. G.; Carroll, J. A.; Lebrilla, C. B., Coordination of alkali metals to
oligosaccharides dictates fragmentation behavior in matrix assisted laser desorption ionization/fourier
transform mass spectrometry. J. Amer. Chem. Soc. 1996, 118, 6736-6745.
33.
Reis, A.; Domingues, M. R. M.; Domingues, P.; Ferrer-Correia, A. J.; Coimbra, M. A., Positive
and negative electrospray ionisation tandem mass spectrometry as a tool for structural characterisation of
acid released oligosaccharides from olive pulp glucuronoxylans. Carbohydr Res 2003, 338, 1497-505.
34.
Fredriksson, S.-A.; Nilsson, B., Sequence analysis of derivatized oligosaccharides by electrospray
tandem mass spectrometry. Adv. Mass Spectrom. 1998, 14, C025930/1-C025930/14.
35.
Jansson, P. E.; Kenne, L.; Liedgren, H.; Lindberg, B.; Lonngren, J., A practical guide to the
methylation analysis of carbohydrates. Chem. Commun., Univ. Stockholm 1976, 75 pp.
36.
Vvedenskaya, I. O.; Rosen, R. T.; Guido, J. E.; Russell, D. J.; Mills, K. A.; Vorsa, N.,
Characterization of flavonols in cranberry (Vaccinium macrocarpon) powder. J. Agric. Food Chem. 2004,
52, 188-195.
37.
Sudjaroen, Y.; Hull, W. E.; Erben, G.; Wuertele, G.; Changbumrung, S.; Ulrich, C. M.; Owen, R.
W., Isolation and characterization of ellagitannins as the major polyphenolic components of Longan
(Dimocarpus longan Lour) seeds. Phytochemistry (Elsevier) 2012, 77, 226-237.
38.
Islam, S. M.; Richards, M. R.; Taha, H. A.; Byrns, S. C.; Lowary, T. L.; Roy, P.-N.,
Conformational analysis of oligoarabinofuranosides: overcoming torsional barriers with umbrella
sampling. J. Chem. Theory Comp. 2011, 7, 2989-3000.
39.
Su, X.; Howell, A. B.; D'Souza, D. H., Antiviral effects of cranberry juice and cranberry
proanthocyanidins on foodborne viral surrogates - A time dependence study in vitro. Food Microbiol.
2010, 27, 985-991.
40.
Kim, K. K.; Singh, A. P.; Singh, R. K.; DeMartino, A.; Brard, L.; Vorsa, N.; Lange, T. S.; Moore,
R. G., Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer
cells. Int. J. Oncol. 2012, 40, 227-235.
41.

Guay, D. R. P., Cranberry and urinary tract infections. Drugs 2009, 69, 775-807.

42.
Isgro, G.; Micali, S.; Bianchi, G.; Miceli, N.; Calapai, G.; Navarra, M., Cranberry and recurrent
cystitis: more than marketing? Crit. Rev. Food Sci. Nutr., Ahead of Print.
73

43.
Jepson, R. G.; Craig, J. C., Cranberries for preventing urinary tract infections. Cochrane database
of systematic reviews (Online) 2008, CD001321.
44.

Foxman, B., The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010, 7, 653-60.

45.
Zafriri, D.; Ofek, I.; Adar, R.; Pocino, M.; Sharon, N., Inhibitory activity of cranberry juice on
adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob. Agents
Chemother 1989, 33, 92-8.
46.
Howell, A. B.; Vorsa, N.; Der, M. A.; Foo, L. Y., Inhibition of the adherence of P-fimbriated
Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N. Engl. J.
Med. 1998, 339, 1085-6.
47.
Gupta, K.; Chou, M. Y.; Howell, A.; Wobbe, C.; Grady, R.; Stapleton, A. E., Cranberry products
inhibit adherence of P-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells.
J. Urol. (N. Y., NY, U. S.) 2007, 177, 2357-2360.
48.
Abu-Lail, L. T., Yaunyuan; Pinzon-Arango, Paola A.; Howell, Amy; Camesano, Terri A., Using
atomic force microscopy to measure anti-adhesion effects on uropathogenic bacteria, observed in urine
after cranberry juice consumption. J. Biomat. Nanobiotech. 2012, 4A, 533-540.
49.
Tao, Y.; Pinzon-Arango, P. A.; Howell, A. B.; Camesano, T. A., Oral consumption of cranberry
juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. J. Med. Food
2011, 14, 739-745.
50.
Howell, A. B.; Reed, J. D.; Krueger, C. G.; Winterbottom, R.; Cunningham, D. G.; Leahy, M., Atype cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry
(Elsevier) 2005, 66, 2281-2291.
51.
Turner, A.; Chen, S.-N.; Joike, M. K.; Pendland, S. L.; Pauli, G. F.; Farnsworth, N. R., Inhibition
of uropathogenic Escherichia coli by cranberry juice: A new antiadherence assay. J. Agric. Food Chem.
2005, 53, 8940-8947.
52.
Wang, C.; Zuo, Y.; Vinson, J. A.; Deng, Y., Absorption and excretion of cranberry-derived
phenolics in humans. Food Chem. 2012, 132, 1420-1428.
53.
Iswaldi, I.; Arraez-Roman, D.; Gomez-Caravaca, A. M.; Contreras, M. d. M.; Uberos, J.; SeguraCarretero, A.; Fernandez-Gutierrez, A., Identification of polyphenols and their metabolites in human
urine after cranberry-syrup consumption. Food Chem. Toxicol. 2013, 55, 484-492.
54.
Salminen, A.; Loimaranta, V.; Joosten, J. A. F.; Khan, A. S.; Hacker, J.; Pieters, R. J.; Finne, J.,
Inhibition of P-fimbriated Escherichia coli adhesion by multivalent galabiose derivatives studied by a
live-bacteria application of surface plasmon resonance. J. Antimicrob. Chemother. 2007, 60, 495-501.
55.
Zhang, J. R., Aziz A.; Jain, Surendra; Jacob, Melissa R.; Khan, Shebana I.; Tekwani, Babu L.;
Ilias, Mohammad, Antimicrobial and antiparasitic abietane diterpenoids from Cupressus sempervirens.
Res. Rep.Med. Chem. 2012, 2, 1-6.
56.
Rahman, A. A.; Samoylenko, V.; Jacob, M. R.; Sahu, R.; Jain, S. K.; Khan, S. I.; Tekwani, B. L.;
Muhammad, I., Antiparasitic and antimicrobial indolizidines from the leaves of Prosopis glandulosa var.
glandulosa. Planta Med. 2011, 77, 1639-1643.
74

57.
NCCLS Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts;
Approved Standard M27-A2; National Committee on Clinical Laboratory Standards: 2002.
58.
NCCLS Methods for Dilution of Antimicrobial Susceptibility Tests for bacteria that Grow
Aerobically, Approved Standard, Seventh Edition; National Committee on Clinical Laboratory Standards:
2006.
59.
NCCLS Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes;
Tentative Standard-Approved Standard, M24-A; National Committee on Clinical Laboratory Standards:
2003.
60.
NCCLS Reference method for broth dilution antifungal susceptibility testing of filamentous fungi;
approved standard, M38-A; National Committee on Clinical Laboratory Standards: 2002.
61.
Evans, D. G.; Evans, D. J.; Tjoa, W., Hemagglutination of human group A erythrocytes by
enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor.
Inf. Immun. 1977, 18, 330-337.
62.
Pollard, P. C.; Moriarty, D. J. W., Validity of the tritiated thymidine method for estimating
bacterial growth rates: measurement of isotope dilution during DNA synthesis. Appl. Environ. Microbiol.
1984, 48, 1076-83.
63.
Soares, S.; Mateus, N.; de, F. V., Carbohydrates inhibit salivary proteins precipitation by
condensed tannins. J. Agric. Food Chem. 2012, 60, 3966-3972.
64.
de Frietas, F. V.; Carvalho, E.; Mateus, N., Study of carbohydrate influence on protein-tannin
aggregation by nephelometry. Food Chem. 2003, 81, 503-509.

75

LIST OF APPENDICES

76

APPENDIX A: 2D NMR SPECTRA OF COMPOUND 1

77

78

HSQC

79

H2BC

80

HMBC

81

COSY

82

Phase-sensitive COSY

83

TOCSY

84

HSQC-TOCSY

85

NOESY

APPENDIX B: 2D NMR SPECTRA OF COMPOUND 2

86

87

HSQC

88

H2BC

89

HMBC

90

COSY

91

TOCSY

92

HSQC-TOCSY

93

NOESY

VITA
EDUCATION
B.S. Botany, minor in Wildlife Biology
Graduated Summa cum Laude
Humboldt State University, Arcata, CA, 95521

Aug. 2004 - May 2008

Associate of Applied Science, Fisheries and Wildlife
Central Oregon Community College, Bend, OR, 97701

Sept. 2002 – June 2004

RESEARCH POSITIONS
Jan. 2011 – present

Graduate Research Assistant

The University of Mississippi, Department of Pharmacognosy, Oxford, MS
- Extraction and isolation using various chromatographic techniques
- Structure elucidation of carbohydrates from Vaccinium macrocarpon Aiton using 1D and 2D
NMR, GC-MS, and MS-MS
- Derivatization of complex carbohydrates
- Human urinary metabolite analysis
- Advisor: Dr. Daneel Ferreira
Visiting Scholar

June 2010 - Aug. 2010

National Center for Natural Products Research, The University of Mississippi, University, MS
- Composition analysis of the lichen Lobaria oregana
- Extraction and isolation using various chromatographic techniques
- Structure elucidation using 1D and 2D NMR and MS
- Supervisor: Ms. Julie Mikell
Field Botanist

June 2009- Aug. 2009

University of Washington, School of Forest Resources, Seattle, WA
- Ecological data collection along permanent transects in the Cascade Mountains of Oregon
- Plant identification and vegetation monitoring
- Supervisors: Dr. Charles Halpern and Dr. Ryan Haugo

94

TEACHING POSITIONS
Sept. 2011 – May 2013

Graduate Teaching Assistant
The University of Mississippi, School of Pharmacy,
Department of Pharmacognosy, Oxford, MS
Instructor

March 2009 - Dec. 2010

COCC, Dept. of Natural and Industrial Resources, Bend, OR
Plant Identification and Forest Ecology
Department Chair and Supervisor: Dr. Michael Fisher
COCC Tutor

Sept. 2008 - Dec. 2010

COCC, Department of Testing and Tutoring, Bend, OR
OTHER POSITIONS
Sept. 2008 – June 2009

COCC Arboretum Project

COCC, Special Grant, Bend, OR
- Inventory, identification, and mapping of all planted trees on the college campus
- Supervisors: Jim Jones (VP & Chief Financial Officer), Dr. Christine Ott-Hopkins
AWARDS AND HONORS
AWARDS
- Teaching Assistant of the Year for the PY2 class 2013
The University of Mississippi, School of Pharmacy
-

GSC Research Day Poster Award, 2nd Prize
The University of Mississippi, Graduate Student Concil

-

Best Student Poster Presentation
International Congress on Natural Products Research, New York City, August 2012

-

Best Podium Presentation
The University of Mississippi, Dept. of Pharmacognosy Annual Retreat, University, MS,
August 2011
95

-

Dennis K. Walker Botany Award
Humboldt State University, Dept. of Biological Sciences, Arcata, CA 95521, May 2008

-

Governor’s Scholars Award
State of California, 2001

HONORS
-

Summa cum Laude graduate
Humboldt State University, Dept. of Biological Sciences, Arcata, CA 95521, May 2008

-

Presidential Scholar
Humboldt State University, Dept. of Biological Sciences, Arcata, CA 95521, Aug. 2004May 2008

-

Dean’s List
Central Oregon Community College, Bend, OR, 97701, Sept. 2002 – June 2004

ORAL PRESENTATIONS
“Breaking it down: Approaches to complex carbohydrate structural analysis”
May 2012
th
Auker, K. and D. Ferreira. 39 Annual MALTO – Medicinal Chemistry-Pharmacognosy Meeting
University of Louisiana at Monroe, LA
“From HIV to cancer: The CXCR4 G-protein coupled receptor as a therapeutic drug target”
March 2012
Auker, K. Spring 2012 Pharmacognosy Seminar Series
The University of Mississippi, University, MS
“Breaking it down: Approaches to complex carbohydrate structural analysis”
Auker, K. and D. Ferreira. Pharmacognosy Departmental Retreat 2011
The University of Mississippi, University, MS

96

August 2011

